In a 2025 qualitative analysis of payer insights conducted by McKesson and Lumanity, 20 payers representing nearly 280 million covered lives reported that although they broadly view CGTs as safe (90%) ...

Texas AG Ken Paxton accuses J&J and Kenvue of deceptive marketing of acetaminophen as safe during pregnancy, alleging concealed risks to fetal development. The lawsuit cites violations of Texas ...

AI is revolutionizing healthcare by improving diagnostics, reducing clinician workload, and enhancing care access, ...

MPN-U patients exhibit lower platelet counts and higher venous thrombosis rates compared to ET, with thrombosis often ...

Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...

People with obesity have an increased risk of developing diffuse large B-cell lymphoma (DLBCL), according to a new report that looked at correlations between genetically determined body mass index ...

Panelists discuss how prescription digital therapeutics differ from traditional pharmaceuticals by following FDA medical ...

Panelists discuss how the treatment landscape has evolved from limited options to include hypomethylating agents and ...

Experts discuss the importance of safe, effective topical therapies for long-term management of atopic dermatitis, ...

Experts discuss the impact of severe eczema on children’s daily lives and the role of newer non-steroidal topical therapies ...

Panelists discuss how schizophrenia imposes significant economic costs across direct medical expenses, nonmedical expenses, and indirect costs, with negative symptoms particularly amplifying the ...

Panelists discuss how combination trials like VIALE-A and VIALE-C have demonstrated venetoclax’s survival benefits when added ...